SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Appendix 3Y

15 May 2020 09:00

RNS Number : 9003M
Danakali Limited
15 May 2020
Β 

Rule 3.19A.2

Appendix 3Y

Β 

Change of Director's Interest Notice

Β 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Β 

Name of entity DANAKALI LTD

ABN 56 097 904 302

Β 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Β 

Name of Director

Andre Liebenberg

Date of last notice

16 June 2019

Β 

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Β 

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Β 

Direct or indirect interest

Indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

Β 

Jane Liebenberg - Spouse of Andre Liebenberg

Date of change

11 May 2020

Β 

No. of securities held prior to change

Indirect

Β 

500,000 Unlisted Options (remuneration) at $0.912, expiring on 11/05/2020

Class

Unlisted Options at $0.912, expiring on 11/05/2020

Β 

Number acquired

Nil

Number disposed

500,000

Β 

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

N/A

Β 

Β 

No. of securities held after change

Nil

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Expiry of unlisted options

Β 

Β 

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

N/A

Nature of interest

N/A

Name of registered holder

(if issued securities)

N/A

Date of change

N/A

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

Β 

N/A

Interest acquired

N/A

Interest disposed

N/A

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

Β 

N/A

Interest after change

N/A

Β 

Part 3 - +Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?

No

If so, was prior written clearance provided to allow the trade to proceed during this period?

N/A

If prior written clearance was provided, on what date was this provided?

N/A

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCDZGMKNDNGGZG
Date   Source Headline
10th Sep 20217:00 amRNSIssue of unlisted option & PDMR/PCA notifications
1st Sep 20217:02 amRNSTotal Voting Rights and Capital
1st Sep 20217:01 amRNSHalf-year Report
1st Sep 20217:00 amRNSChange to Board of Directors
11th Aug 20217:00 amRNSProposed Cancellation of London Listing
6th Aug 20217:56 amRNSIssue of Shares and Unlisted Options
2nd Aug 20217:00 amRNSTotal Voting Rights and Capital
30th Jul 20217:00 amRNSAmended Constitution
30th Jul 20217:00 amRNSResult of AGM
29th Jul 20217:00 amRNSQuarterly Activities Report and Appendix 5B
5th Jul 20217:00 amRNSCompany Presentation and Video
1st Jul 202111:06 amRNSNotice of AGM
1st Jul 20217:00 amRNSTotal Voting Rights
25th Jun 20219:31 amRNSNotification of PDMR transaction
25th Jun 20217:26 amRNSProposed issue of unlisted options
17th Jun 20217:00 amRNSColluli Project Update
11th Jun 20217:17 amRNSReport on Payments to Governments
1st Jun 20217:00 amRNSTotal Voting Rights and Capital
27th May 20217:00 amRNSColluli Project Update
21st May 20217:52 amRNSAppendix 3Y
21st May 20217:48 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSColluli Project - RO Plant Manufacturing Underway
12th May 20217:01 amRNSA$20.3M Placement Endorses Danakali's SOP Project
12th May 20217:00 amRNSCorrection of Announcement - Issue of Shares
6th May 20219:12 amRNSIssue of shares
6th May 20217:00 amRNSNotification of PDMR and PCA transactions
30th Apr 20219:53 amRNSAnnual Report to Shareholders
30th Apr 20217:00 amRNSQuarterly Activities Report and Appendix 5B
29th Apr 20217:05 amRNSCompany Presentation
29th Apr 20217:00 amRNSA$20.3M Placement to Advance Colluli
27th Apr 20217:00 amRNSASX Trading Halt and Proposed Fundraise
19th Apr 202110:15 amRNSAdviser Appointment
13th Apr 20217:00 amRNSResignation of CFO
6th Apr 20217:00 amRNSCorrection to Corporate Presentation
6th Apr 20217:00 amRNSTotal Voting Rights and Capital
31st Mar 20217:26 amRNSRelease of 2020 Financial Report
26th Mar 20217:00 amRNSExecutive Chairman remuneration
24th Mar 20219:31 amRNSIssue of unlisted options
24th Mar 20219:29 amRNSProposed issue of unlisted options
22nd Mar 20217:34 amRNSCompany Presentation
10th Mar 20217:00 amRNSClean energy zero carbon SOP
2nd Mar 20218:36 amRNSTotal Voting Rights and Capital
26th Feb 20217:00 amRNSAppointment of Executive Chairman and restructure
23rd Feb 20219:13 amRNSResponse to ASX price and volume query
15th Feb 20219:01 amRNSIssue of shares & options, PDMR/PCA transactions
11th Feb 20217:00 amRNSCompany Presentation
1st Feb 20217:53 amRNSTotal Voting Rights
29th Jan 20217:54 amRNSIssue of unlisted options
29th Jan 20217:50 amRNSProposed issue of securities
28th Jan 20217:37 amRNSQuarterly Report and Appendix 5B

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.